NCT02820610 is a Phase 2 clinical trial of Dexmedetomidine in Analgesia, sponsored by Assiut University.

Who is sponsoring NCT02820610?

NCT02820610 is sponsored by Assiut University.

What drugs are being tested in NCT02820610?

Interventions in NCT02820610: Dexmedetomidine, Magnesium Sulfate, Normal saline 0.9 %.

Is NCT02820610 still recruiting?

NCT02820610 is currently completed. Last updated 1 January 2020.

Last reviewed 2020-01-01 · How we verify

NCT02820610

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dexmedetomidine Versus Magnesium Sulfate as an Adjuvant to Intraperitoneal Bupivacaine for Pain Relief in Children Undergoing Laparoscopic Herniorrhaphy: a Randomized Controlled Study.

Completed Phase 2 Last updated 1 January 2020

What this trial tests

Phase 2 trial testing Dexmedetomidine in Analgesia in 97 participants. Completed in 1 September 2019.

Timeline

1 August 2016

Primary endpoint
1 September 2019

1 September 2019

Quick facts

Lead sponsor	Assiut University
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	97
Start date	1 August 2016
Primary completion	1 September 2019
Estimated completion	1 September 2019
Sites	1 location across Egypt

Drugs / interventions tested

Dexmedetomidine (dexmedetomidine) — full drug profile →
Magnesium Sulfate — full drug profile →
Normal saline 0.9 %

Conditions studied

Analgesia — all drugs for Analgesia →

Sponsor

Assiut University

Who can join

Adults 1 to 6, male only, with Analgesia. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Postoperative pain
Time frame: 48 hr
The Face Legs Activity Cry and Consolability (FLACC) pain score

Sponsor's own description

It is important to keep children undergoing laparoscopic surgery pain free with rapid return to normal activity.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy of dexmedetomidine versus magnesium sulfate as an adjuvant to intraperitoneal bupivacaine in pediatric laparoscopic surgery: a randomized clinical trial.
Moeen SM, Wahba OM, Mandour AM, Ghany NA, et al · · 2024 · cited 2× · PMID 35618084 · DOI 10.1016/j.bjane.2022.05.003

Verify or expand the search:

Other trials of Dexmedetomidine

Trials testing the same drug.

NCT06824077 — Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle · EARLY_PHASE1 · not yet recruiting
NCT07398066 — DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial) · NA · not yet recruiting
NCT07377981 — An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyp · Phase 4 · not yet recruiting
NCT07306702 — Dexmedetomidine-Enhanced PCIA After Lobectomy in Nicotine-Dependent Patients · Phase 4 · withdrawn
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting

Other recruiting trials for Analgesia

Currently open trials in the same condition.

NCT07249827 — A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guid · Phase 2 · recruiting
NCT07250230 — Effect of Perioperative High-dose Transdermal Nicotine Patch on Pain Sensitivity Among Male Abstinent Tobacco Smokers Un · NA · recruiting
NCT07337629 — Single Dose Preemptive Paracetamol or Ibuprofen Before Septrorhinoplasty on Intra- and Postoperative Opioid Consumption. · recruiting
NCT07310953 — Clinical Utility of the Numerical Verbal Scale (NVS) and the Pain and Functional Activity Scale (PFAS) in the Management · NA · recruiting
NCT06869967 — Evaluation of Postoperative Pain Control in Ear Surgery · NA · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02820610 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 1 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02820610.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing